Bioavailability Study of Letrozole Tablets 2.5 mg of Dr.Reddy's Under Fed Conditions
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Letrozole
Related studies linked through entity extraction aliases.
Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Bioequivalency Study of Letrozole 2.5 mg Tablets Under Fasted Conditions
- Status
- COMPLETED
- Phase
- PHASE1
Bioequivalency Study of Letrozole 2.5 mg Tablets Under Fed Conditions
- Status
- COMPLETED
- Phase
- PHASE1
Letrozole for Lymphangioleiomyomatosis
- Status
- COMPLETED
- Phase
- PHASE2
Dosage Optimization for Letrozole Treatment
- Status
- COMPLETED
- Phase
- PHASE4
A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma (NHL) and in Combination With Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
PhIb BKM120 or BEZ235+Endocrine Treatment in Post-Menopausal Patients With Hormone Receptor + Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of RAD001 (Everolimus) in Combination With Letrozole in the Treatment of Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of BMS-754807 Combined With Letrozole or BMS-754807 Alone in Patients With Hormone Receptor-Positive Breast Cancer and Resistance to Non-Steroidal Aromatase Inhibitors
- Status
- TERMINATED
- Phase
- PHASE2
RO4929097 and Letrozole in Treating Post-Menopausal Women With Hormone Receptor-Positive Stage II or Stage III Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-Sensitive Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms
- Status
- COMPLETED
- Phase
- PHASE2
Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy
- Status
- COMPLETED
- Phase
- NA
Effect of Aromatase Inhibitors on Breast Magnetic Resonance Imaging (MRI)
- Status
- COMPLETED
- Phase
- PHASE2
Polycystic Ovary Syndrome (PCOS): Effect Of Letrozole and Berberine
- Status
- UNKNOWN
- Phase
- NA
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Extended Adjuvant Treatment With Letrozole in Breast Cancer Who Complete 5 Years of Toremifene
- Status
- UNKNOWN
- Phase
- PHASE4